Show simple item record

Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?

dc.contributor.authorPavlidis, Nicholasen
dc.contributor.authorNikolaou, N.en
dc.contributor.authorCh, F. Tolisen
dc.contributor.authorOrfanos, S.en
dc.contributor.authorTolis, G.en
dc.creatorPavlidis, Nicholasen
dc.creatorNikolaou, N.en
dc.creatorCh, F. Tolisen
dc.creatorOrfanos, S.en
dc.creatorTolis, G.en
dc.date.accessioned2018-06-22T09:54:19Z
dc.date.available2018-06-22T09:54:19Z
dc.date.issued1989
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/42302
dc.description.abstractA patient with hypogonadotropic hypogonadism owing to endogenous gonadotropin releasing hormone deficiency, who developed Hodgkin's disease is described. Chemotherapy administration caused prolonged and life‐threatening myelosuppression; androgen substitution seemed to reverse bone marrow function and to maintain normal peripheral blood counts. Whether or not androgens are a necessary substitution in hypogonadal patients suffering from cancer and undergoing chemotherapy is discussed. Copyright © 1989 Wiley‐Liss, Inc., A Wiley Companyen
dc.language.isoengen
dc.sourceMedical and pediatric oncologyen
dc.subjectCanceren
dc.subjectCancer chemotherapyen
dc.subjectChlormethineen
dc.subjectHumanen
dc.subjectPrednisoneen
dc.subjectProcarbazineen
dc.subjectVincristineen
dc.subjectAgeden
dc.subjectPriority journalen
dc.subjectBone marrowen
dc.subjectAntineoplastic combined chemotherapy protocolsen
dc.subjectBone marrow suppressionen
dc.subjectMaleen
dc.subjectCase reporten
dc.subjectDisease associationen
dc.subjectHodgkin diseaseen
dc.subjectTestosteroneen
dc.subjectBone marrow diseasesen
dc.subjectHypogonadismen
dc.subjectHypogonadotropic hypogonadismen
dc.subjectMechlorethamineen
dc.subjectMyelosuppression androgensen
dc.subjectNandroloneen
dc.subjectPituitary hormone-releasing hormonesen
dc.titleIs androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?en
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/mpo.2950170310
dc.description.volume17
dc.description.issue3
dc.description.startingpage222
dc.description.endingpage226
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidPavlidis, Nicholas [0000-0002-2195-9961]
dc.gnosis.orcid0000-0002-2195-9961


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record